These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3274810)

  • 21. Requirement for DR sharing in stable kidney allograft tolerance induced by donor bone marrow in rhesus monkeys.
    Thomas J; Kasten-Jolly J; Verbanac K; Smith JP; Carver M; Gross U; Rebellato L; Thomas F; Haisch C
    Transplant Proc; 1995 Feb; 27(1):166-8. PubMed ID: 7878957
    [No Abstract]   [Full Text] [Related]  

  • 22. Donor bone marrow cell facilitates induction of tolerance to kidney allografts in dogs treated with fractionated lymphoid irradiation and FK 506.
    Watanabe K; Yuge K; Sato K; Sonoda K; Masaki Y; Maruyama S; Okubo M; Obata F; Otani F; Kaneko T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):568-72. PubMed ID: 1703706
    [No Abstract]   [Full Text] [Related]  

  • 23. Active enhancement of tissue allografts with antilymphocyte serum and bone marrow.
    Monaco AP; Liegeois A; Wood ML; Clark AW
    Adv Nephrol Necker Hosp; 1975; 5():135-72. PubMed ID: 242206
    [No Abstract]   [Full Text] [Related]  

  • 24. The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys.
    Thomas JM; Verbanac KM; Smith JP; Kasten-Jolly J; Gross U; Rebellato LM; Haisch CE; Carver FM; Thomas FT
    Transplantation; 1995 Jan; 59(2):245-55. PubMed ID: 7839448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Total lymphoid irradiation.
    Sutherland DE; Ferguson RM; Simmons RL; Kim TH; Slavin S; Najarian JS
    Urol Clin North Am; 1983 May; 10(2):277-88. PubMed ID: 6344387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerance induction in a large-animal model using total lymphoid irradiation and intrathymic bone marrow.
    Horton PJ; Hawthorne WJ; Walters S; Patel T; Stewart GJ; Allen RD; Chapman JR
    Transplantation; 2008 Dec; 86(12):1830-6. PubMed ID: 19104430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cyclosporin A supplementation and on renal allograft survival in ALS plus bone marrow treated dogs.
    Hartner WC; De Fazio SR; Markees TG; Khouri WA; Maki T; Monaco AP; Gozzo JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):959-60. PubMed ID: 2650299
    [No Abstract]   [Full Text] [Related]  

  • 31. Improved large burn therapy with reduced mortality following an associated septic challenge by early excision and skin allografting using donor-specific tolerance.
    Garrison JL; Thomas F; Cunningham P
    Transplant Proc; 1995 Feb; 27(1):1416-8. PubMed ID: 7878931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Spare parts" revisited.
    Rapaport FT
    Transplant Proc; 1975 Sep; 7(3):343-50. PubMed ID: 1099740
    [No Abstract]   [Full Text] [Related]  

  • 33. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
    Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
    Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
    [No Abstract]   [Full Text] [Related]  

  • 34. Augmentation by donor bone marrow of the survival of neonatal skin transplants to ALS-treated recipients.
    Gozzo JJ; Kowolenko M
    Transplant Proc; 1987 Feb; 19(1 Pt 1):470-1. PubMed ID: 3274809
    [No Abstract]   [Full Text] [Related]  

  • 35. [Renal allograft in the dog. A new method for survival prolongation].
    Liégeois A; Caridis T; Barrett I; Monaco AP
    Nouv Presse Med; 1973 May; 2(20):1351-4. PubMed ID: 4577259
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
    Hara Y; Matsuura T; Imanishi M; Tahara H; Kurita T
    Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955
    [No Abstract]   [Full Text] [Related]  

  • 38. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation.
    Shen Z; Mohiuddin M; DiSesa VJ
    Ann Thorac Surg; 1995 Dec; 60(6):1683-5. PubMed ID: 8787463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretreatment of human renal allografts with monoclonal antibodies to induce long-term tolerance.
    Taube D; Welsh KI; Bewick M; Dische FE; Palmer A; Parsons V; Snowden S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1961-3. PubMed ID: 3274456
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of pharmacologic immunosuppression to augment the specific unresponsiveness (tolerance) to skin allografts induced by donor-specific bone marrow in antilymphocyte serum-treated mice: the unique effect of sirolimus.
    Hale D; Gottschalk R; Maki T; Monaco AP
    Transplant Proc; 1998 Aug; 30(5):2432-4. PubMed ID: 9723527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.